Theme: New Insights in Cardiology for a diverse World

Cardiology-2022

Cardiology-2022

We are pleased to announce and welcome you to the " 26th World Cardiology Conference" to be held as a hybrid event in Brussels, Belgium and which is going to be held on July 28-29, 2022.

The global event will focus on the theme " New Insights in Cardiology for a diverse World " and aims to accelerate scientific discoveries and major milestones in current state, trials and research advances in cardiology and related fields.

Gene medicine, device therapy and the innovative cell are among the innovations that are part of a technological revolution in cardiology. These breakthrough technologies represent the beginning of a technological revolution in cardiac patient care and will play a key role in clinical practice.

CARDIOLOGY-2022 will feature a dedicated forum for keynote sessions, oral and poster presentations. With people around the world eager to discover some answers in the field, this is your best chance to meet and collaborate with the most dedicated and distinguished people in medical centers, universities, cardiac associations, and cardiac experts. first class.

We hope you will attend CARDIOLOGY-2022 and take this great opportunity to discuss and stay up to date with new technologies and innovative methods in your area of ​​expertise.

Why to attend?

Encounter the target market with members from across the globe, committed to learn about novel technologies and innovations in Cardiovascular Care. This is the best opportunity to outreach the largest gathering of participants from around the world. Conduct presentations, distribute and update knowledge about the advancements in Clinical Cardiology, Cardiac Imaging, and Cardiac Regeneration and in different fields of cardiology by receiving name recognition at this 2-days event. World-eminent speakers, most recent research, latest treatment techniques and the advanced updates in Cardiology are the principal features of this conference.

Target Audience:

Our organization would be privileged to welcome the:

Directors of Clinical cardiology, Interventional Cardiology, Nuclear Cardiology, Pediatric Cardiology, Sports Cardiology or related Programs or Associations, Heads, Deans and Professors of Clinical cardiology, Interventional Cardiology, Nuclear Cardiology, Pediatric Cardiology, Sports Cardiology and related departments, Scientists and Researchers, doctors.

Founders and Employees of the related companies

Clinical cardiology, Interventional Cardiology, Nuclear Cardiology, Pediatric Cardiology, Sports Cardiology Associations and Organizations

Laboratory members and Students working in the field of Nuclear Cardiology.

Track 1: Clinical Cardiology

Cardiology is a branch of medicine deals with disorders of the heart as well as parts of the circulatory system. The  Section of   Clinical Cardiology access to specialized inpatient, outpatient heart care and treatment of Angina, artery problems, Valvular heart disease, and heart failure. The one who specialize in this field of medicine are called cardiologists, primary mission is to deliver high quality, cardiovascular care to all of our patients. Paediatric cardiologist is paediatricians who have received extensive training in diagnosing and treating children's cardiac problems.

Track 2: Interventional Cardiology

Interventional cardiology is a branch of cardiology with one to two years of additional education and training in diagnosing and treating cardiovascular disease as well as congenital (present at birth) and structural heart conditions through catheter-based procedures such as angioplasty and stenting that deals specifically with the catheter based treatment of structural heart diseases. The event that began the revolution in cardiology was the performance of coronary interventions by Andreas Gruentzig in 1977. It is a non-surgical option which uses a catheter – a small, flexible tube – to repair damaged or weakened vessels, narrowed arteries, or other affected parts of the heart structure. The interventional cardiology or radiology procedures are generally less invasive than traditional surgery. In most cases, these procedures require only one small incision for insertion of the catheter. Most of the patients do not require general anaesthesia and some operation can take as few as 30 minutes to perform and avoidance of the scars and pain, and long post-operative recovery. Interventional Cardiology procedure involves small incision in the arm or groin and threads a catheter into a blood vessel.

Track 3: Paediatric Cardiology

A paediatric cardiologist is a paediatrician who has received extensive training in diagnosing and treating children's cardiac problems. Evaluation and treatment may begin with the foetus since heart problems can now be detected before birth and also responsible for the diagnosis of congenital heart defects, performing diagnostic procedures such as echocardiograms, cardiac catheterizations, and for the on-going management of the sequel of heart disease in infants, children and adolescents. The division is actively involved in research aimed at preventing both congenital and acquired heart disease in children and also Paediatric heart surgeons treat complex congenital heart defects in new-borns, children, as well as adults. Congenital heart deficiency is very unique from the types of heart diseases that are common among adults. Repairing hearts in small bodies’ todays an added challenge.

Track 4: Cardiac Imaging

The cardiac imaging also known as Cardiovascular magnetic resonance imaging (CMR), is a imaging medical technology for the non-nosy assessment of the activity and structure of the cardiovascular system with division of Cardiovascular Imaging clarifies the cross sectional imaging studies of the heart and vascular system using Computed Tomography (CT or "CAT" scans) and Magnetic Resonance Imaging (MRI). Both CT and MRI are non-invasive imaging modality, which uses a powerful magnetic field, radio waves and a computer to produce detailed pictures of the structures within the heart. It is used to detect or monitor cardiac disease and to evaluate the heart's anatomy and function in patients with congenital heart disease. MUSC operates the most up-to-date, cutting edge imaging equipment to ensure optimal diagnostic quality in patient care while also minimizing patient exposure to ionizing radiation.

Track 5: Cardiovascular Disease

Cardiovascular disease (CVD) is a class of diseases that involve the heart or blood vessels. Cardiovascular disease includes coronary artery diseases (CAD) such as angina and myocardial infarction (commonly known as a heart attack). It's usually associated with a build-up of fatty deposits inside the arteries – known as atherosclerosis – and an increased risk of blood clots. It can also be associated with damage to arteries in organs such as the brain, heart, kidneys and eyes. Cardiovascular disease is a term that refers to more than one disease of the circulatory system including the heart and blood vessels, whether the blood vessels are affecting the lungs, the brain, kidneys or other parts of the body.

Track 6: Heart Failure 

Heart failure (HF) sometimes known as congestive heart failure is a common condition that develops after the heart muscle doesn't pump blood as well as it should. Certain conditions, such as narrowed arteries in your heart (coronary artery disease) or high blood pressure, gradually leave your heart too weak or stiff to fill and pump efficiently or weakened by diseases of the heart including heart attacks and other medical conditions. Heart failure occurs when the main pumping chambers of your heart (the ventricles) may become stiff and not fill properly between beats especially during increased activity or under stress. In addition, the heart muscle may become damaged or weakened and couldn’t relax properly to accommodate the flow of blood back from the lungs to the heart. 

Track 7: Diabetic Cardiovascular Disease

The term diabetic cardiovascular disease (DCD) refers to heart disease that develops in people who have diabetes which increases your risk of heart attack and clot-related stroke (cardiovascular events). Peripheral artery disease  — a case in which your arteries narrow, reducing blood discharge to your arms and legs — also increases your risk of cardiovascular accident. Diabetes is a disease in which the body's blood glucose (sugar) level is too high and affects your body's ability to produce or use insulin. Normally, your body turns the food you eat into energy. Insulin is released to aid transport this energy to the cells. Insulin acts as a “key.”

Track 8: Cardiac Regeneration

Cardiac regeneration is reparative stem cells have the capability to restore function to damaged tissue by renewing cell growth in cardiac cells destroyed by heart disease or a rapidly evolving and controversial field of research. The identification some 12 years ago of progenitor cells that reside within the heart spurred enthusiasm for cell-based regenerative therapies and approximately 15.5 million Americans have one or more types of cardiovascular disease, such as heart attack, angina or heart failure. Here’s is heart regeneration strategy which requires the injection of exogenous cells into the affected area of the heart. These transplanted cells could generate and repopulate the injured area with myocardium. Complementary regenerative strategies to cell transplantation are simultaneously being pursued by the field.

Track 9: Echocardiography

An echocardiogram, often referred to as a cardiac echo or simply an echo, is a sonogram of the heart. (It is not abbreviated as ECG, because that is an abbreviation for an electrocardiogram.) Echocardiography uses standard two-dimensional, three-dimensional, and Doppler ultra sound to create images of the heart.
Echocardiography has become routinely used in the diagnosis, management, and follow-up of patients with any suspected or known heart diseases. It is one of the most widely used diagnostic tests in cardiology. It can provide a wealth of helpful information, including the size and shape of the heart (internal chamber size quantification), pumping capacity, and the location and extent of any tissue damage. An echocardiogram can also give physicians other estimates of heart function, such as a calculation of the cardiac output, ejection fraction, and diastolic function (how well the heart relaxes).

Track 10: Critical Cardiac Care

Critical cardiac care (CIC) which is also known as coronary care unit (CCU)  is a hospital ward specialized in the care of patients with heart attacks, unstable angina, cardiac dysrhythmia and (in practice) various other cardiac conditions that require continuous monitoring and treatment or first aid treatment till the doctor comes. There are also units available in the hospitals to take care of the emergency situation. The Cardiac intensive care unit (CICU) is a specialized ICU dealing with cardiac patients and is usually staffed by cardiologists. It offers critical care staff especially trained in acute coronary syndromes and has additional technology such as intra-aortic balloon pumps, etc.

Track 11: Cardiac Surgery

Cardiovascular surgery which is also known as  surgery thoracic surgery is operated on the heart or great vessels by cardiac surgeons and it  is the field of medicine involved in surgical treatment of organs inside the thorax. There are five types of cardiac surgery 1) Open heart surgery 2) Modern beating-heart surgery 3) Heart transplant 4) Coronary artery bypass grafting 5) Minimally invasive surgery and  surgeries are done to treat complexity of ischemic heart disease, correct congenital heart disease, or treat valvular heart disease from various causes including endocarditis, rheumatic heart disease and atherosclerosis and  advancement of cardiac surgery and cardiopulmonary bypass techniques has greatly reduced the mortality rates of these procedures. The surgery requires postoperative care to avoid complications. Laceration care is needed to avoid infection and minimize scarring. Swelling and loss of appetite are common, As mentioned Coronary artery bypass grafting (CABG) is the most common type of heart surgery. CABG improves blood flow to the heart.

Track 12: Cardio-oncology

Cancer and cardiovascular disease are the leading causes of mortality in many parts of the world and Cardio-oncology is the intersection of heart conditions in patients who have been treated for cancer. There are several reasons for both diseases occurring in the same patient. Coronary artery disease (CAD) and Cancer share risk factors such as age, use of tobacco and obesity. Other reasons may be the consequences of radio- and chemo-therapy in long-term survivors of malignancy. These treatments have a direct impact on the heart, which require, in some cases, surgical correction. Malignancy can also occur during long-term follow-up after coronary artery bypass graft (CABG). The increase in diagnostic facilities makes the detection of heart disease and treatable cancer also more likely.

Track 13: Atherosclerosis

Atherosclerosis is a common form of heart disease of the arteries characterized by the deposition of plaques of fatty material on their inner walls eventually restricts blood flow and plaque is made up of fat, cholesterol, calcium, and other substances found in the blood later plaque hardens and narrows your arteries which limits the flow of oxygen-rich blood to your organs and other parts of your body and this constricted circulation leads to less oxygen for the heart muscle, resulting in chest pain (angina), usually following exercise or excitement. It can also lead to serious problems, including heart attack, stroke, and stresses the heart muscle to the point of failure, which is what happens during a heart attack which may even lead to death. The disease can influence any artery in the body along with arteries in the heart, brain, arms, legs, pelvis, and kidneys which results in different diseases may develop based on which arteries are affected.

Track 14: Obesity and Heart

People with a body mass index (BMI) of 30 or higher are considered obese. The term obesity is used to describe the health condition of anyone significantly above his or her ideal healthy weight. Obesity increases the risk for heart disease and stroke. But it harms more than just the heart and blood vessel system. It's also a major cause of gallstones, osteoarthritis and respiratory problems. Obesity is intimately intertwined with multiple health conditions that underlie cardiovascular disease including high blood pressure, diabetes, and abnormal blood cholesterol. In addition, weight gain is a frequent consequence of heart-damaging lifestyle choices such as lack of exercise and a fat-laden diet. Obesity also can lead to heart failure. This is a serious condition in which your heart can't pump enough blood to meet your body's needs.

Track 15: Cardiac Medications

Cardiology conferences include the Cardiac Drugs which are used in any way to treat conditions of the heart or the circulatory or vascular system. Many classes of cardiovascular agents are available to treat the various cardiovascular conditions. They are a complicated group of drugs with many being used for multiple heart conditions. Prescription drugs and medicines for diseases related to the structure and function of the heart and blood vessels. In this sub topic we have Sodium, potassium, calcium channel blockers, ACE-inhibitors and Cardiac biomarkers. There are 6 associations and societies and the main association for Cardiac Therapeutic Agents in USA. 50 universities are working on Cardiac Therapeutic Agents.

Track 16: Sports Cardiology

Sports Cardiology achieves heart screenings that detect potentially serious cardiovascular issues in young athletes. Sudden cardiac arrest (SCA) is the major reason of death in exercising young athletes, and is most commonly set off by problems as structural heart disorders or electrical circuitry issues which are not commonly found during routine physical examinations. Most of the conditions that cause sudden cardiac death in young athletes are evaluated by an electrocardiogram (ECG or EKG), a non-invasive test which calculates the electrical activity of the heart.

Track 17: Current Research in Cardiology

Advances in medicine means that if CHD is detected at an early stage it can be treated successfully to extend the survival rate. Successful treatment is more likely if the disease is detected at its earliest stages. Our current research focuses on the early detection of CHD in order to halt or reverse the progress of the disease. The on-going research includes pioneering the use of heart scanning in the early diagnosis of heart disease in diabetics, Development of Nuclear Cardiology techniques for the detection of heart disease, Drug development and evaluation of treatments used in heart disease, Identification of novel biological markers to predict the presence of heart disease, Analysis of ethnic and socio-economic differences in heart disease risk.

The Cardiology market is growing rapidly and is expected to reach $97 billion by 2018 globally. Worldwide Interventional Cardiac Devices business sector was worth US$20.6 billion in 2016, developing at a CAGR of 9.2% during 2012-2018 market analysis. North American region represents most astounding rate roughly 35.8% (2015) of worldwide offer while Europe is the 2nd leader with almost 28.8% (2018) of the business sector. Asia-Pacific is the quickest developing region with a CAGR of 11.6% driving a business sector estimation of US$4.7 billion.

Rate of Cardiovascular Diseases:

As estimated 17.7 million people died from Cardiovascular diseases in 2015, representing 31% of all the global deaths. Of these deaths, an estimated 7.4 million were due to coronary heart disease and 6.7 million were due to Heart stroke. Out of the 17 million premature deaths due to non-communicable diseases in 2015, 82% are in low and middle income countries, and 37% are caused by Cardiovascular Diseases.

CardioVascular Surgery Devices Market:

The global cardiovascular device industry is growing rapidly and exhibits signs that will continue to evolve and expand to reach $97 billion by 2017, up from nearly $85 billion in 2010 according to the study from BCC Research. The United States have the biggest market for cardiovascular surgery devices, contributing to 38% and accounting for $688million of the global market in 2010. The cardiovascular surgery devices market in the US is forecast to decline at a CAGR of 1.6%, to reach the market value of $616.1million in 2017. And in 2010 Medtronic was the largest player in the global cardiovascular surgery devices market with the market share of 24%. This was followed by Sorin with 19%, Maquet with 15% and Terumo Corporation with 5% of the share.

Universities of Cardiology:

Globally:

University of Louisville, Kentucky

University of Chicago, Chicago

Stanford University Medical Center, California

Duke University Hospital, Durham

University of Southern California, Los Angeles

Kasturba Medical College, India

University in Little Rock, Arkansas

Thomas Jefferson University, Philadelphia

ohio state medical centre, Colombus

Japan:

Osaka University Hospital, Osaka

Kanazawa University Hospital, Kanazawa

The University of Tokyo Hospital Cardiac & Thoracic Surgery, Tokyo

Kyoto University, Kyoto

Kobe University, Kobe

Okayama University, Japan

Nagoya University, Nagoya

Hospitals for Cardiovascular and Thoracic Surgery in Japan:

IMS Katsushika Heart Center, Tokyo

The Cardiovascular Institute Hospital, Tokyo

The University of Tokyo Hospital Cardiac & Thoracic Surgery, Tokyo

Chiba University Hospital, Inohana

Okayama University Hospital, Japan

AUnique Opportunity for Advertisers and Sponsors at this International  event:  https://cardiologycongress.conferenceseries.com/ 

 

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date July 28-29, 2022
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Closed
Poster Opportunity Closed Click Here to View